VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Est. Return
12.28%
1 Year Est. Return
-12.28%
AUM
$1.4B
AUM Growth
-$286M
(-17%)
Holding
86
Top Buys
| 1 | +$125M | |
| 2 | +$50.3M | |
| 3 | +$41.8M | |
| 4 |
Vera Therapeutics
VERA
|
+$34.2M |
| 5 |
Nuvalent
NUVL
|
+$33.7M |
Top Sells
| 1 | +$120M | |
| 2 | +$79.6M | |
| 3 | +$57.6M | |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$56.5M |
| 5 |
Soleno Therapeutics
SLNO
|
+$47.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$4.7B
| $157M | 11.19% |
2,387,720
+1,912,720
|
|
||
2
Cytokinetics
CYTK
$6.92B
| $104M | 7.44% |
2,590,531
+240,531
|
|
||
3
Insmed
INSM
$33.7B
| $82M | 5.86% |
1,075,000
+175,000
|
|
||
|
4
Nuvalent
NUVL
$6.73B
| $76.2M | 5.44% |
1,075,000
+475,000
|
|
||
|
5
Vera Therapeutics
VERA
$1.86B
| $60M | 4.29% |
2,500,000
+1,425,000
|
|
||
6
KalVista Pharmaceuticals
KALV
$562M
| $54.8M | 3.92% |
4,751,292
-18,708
|
|
||
7
uniQure
QURE
$3.76B
| $50.8M | 3.63% |
4,792,572
+1,767,572
|
|
||
8
Crinetics Pharmaceuticals
CRNX
$3.86B
| $50.3M | 3.59% |
+1,500,000
|
|
||
9
Xenon Pharmaceuticals
XENE
$3.14B
| $43.6M | 3.11% |
1,300,000
+490,000
|
|
||
10
Scholar Rock
SRRK
$2.85B
| $41.8M | 2.98% |
+1,300,000
|
|
||
|
BCAX
11
Bicara Therapeutics
BCAX
$936M
| $36.1M | 2.58% |
2,768,975
+2,058,975
|
|
||
12
Geron
GERN
$791M
| $35M | 2.5% |
22,005,340
+11,005,340
|
|
||
13
Amicus Therapeutics
FOLD
$2.67B
| $34.9M | 2.49% |
4,275,000
+925,000
|
|
||
14
Immatics
IMTX
$1.24B
| $32.4M | 2.32% |
7,192,700
+917,700
|
|
||
15
Structure Therapeutics
GPCR
$1.52B
| $31M | 2.21% |
1,788,990
+63,990
|
|
||
16
Dianthus Therapeutics
DNTH
$1.31B
| $30.8M | 2.2% |
1,700,069
+625,069
|
|
||
17
Savara
SVRA
$754M
| $30.5M | 2.18% |
11,000,000
+225,000
|
|
||
18
Tyra Biosciences
TYRA
$758M
| $26.8M | 1.91% |
2,879,829
+1,889,829
|
|
||
19
Danaher
DHR
$158B
| $25.6M | 1.83% |
+125,000
|
|
||
20
UroGen Pharma
URGN
$878M
| $23.8M | 1.7% |
2,152,957
+522,957
|
|
||
21
Ascendis Pharma
ASND
$12.2B
| $23.4M | 1.67% |
150,142
-369,858
|
|
||
22
Astria Therapeutics
ATXS
$702M
| $22.3M | 1.59% |
4,180,000
|
|
||
23
Day One Biopharmaceuticals
DAWN
$767M
| $20.6M | 1.47% |
2,598,127
+1,158,127
|
|
||
24
Dyne Therapeutics
DYN
$2.44B
| $18.8M | 1.34% |
+1,800,000
|
|
||
25
Ultragenyx Pharmaceutical
RARE
$3.23B
| $18.1M | 1.29% |
500,000
-1,000,000
|
|